
Sign up to save your podcasts
Or


This week, 2 new COVID-19 studies (doi:10.1001/jama.2020.6771 and doi: 10.1001/jama.2020.6775), an effective treatment for irritable bowel syndrome (https://www.ncbi.nlm.nih.gov/pubmed/31852769), and trends in prostate cancer screening (https://www.ncbi.nlm.nih.gov/pubmed/31794057).
By Mark Ebell4.7
9292 ratings
This week, 2 new COVID-19 studies (doi:10.1001/jama.2020.6771 and doi: 10.1001/jama.2020.6775), an effective treatment for irritable bowel syndrome (https://www.ncbi.nlm.nih.gov/pubmed/31852769), and trends in prostate cancer screening (https://www.ncbi.nlm.nih.gov/pubmed/31794057).

134 Listeners

701 Listeners

504 Listeners

298 Listeners

305 Listeners

264 Listeners

3,374 Listeners

1,150 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

251 Listeners

375 Listeners

320 Listeners